Arphio's CEO Dr. Shlomo Sadoun's Insights Elevate Pharma Synergy Event


During the first week of February 2024, Arphio’s CEO, Dr. Shlomo Sadoun, was proud to be one of the key speakers participating at the prestigious Pharma Synergy event in London. With over 230 executives representing 62 countries in attendance, Dr. Sadoun's invaluable contributions played a pivotal role in enriching the event and fostering meaningful discussions.

The event, which brought together industry leaders and experts from around the world, served as a platform for exchanging ideas, insights, and strategies to address the evolving challenges in healthcare, particularly in the realm of rare diseases.

Dr. Sadoun's expertise and visionary outlook resonated profoundly with the audience, sparking engaging discussions and inspiring innovative approaches to tackling complex issues.

Following Dr. Sadoun’s presentation on the dynamic and ever-evolving landscape of orphan drug development, he stated that "Embracing innovation and collaboration is paramount in our pursuit of transformative solutions for rare diseases. By uniting our efforts and leveraging cutting-edge technologies, we can redefine the future of healthcare and bring hope to those in need."

Arphio remains committed to driving positive change in the healthcare landscape, with a focus on pioneering solutions for rare diseases. The company expresses sincere gratitude to all stakeholders for their ongoing support and looks forward to continued collaboration in advancing rare disease solutions.

Reach out to us to partner up!

At Arphio, our mission is to make treatments for rare diseases accessible to a wide international population. Get in touch today! - VP, Business Development - Director, Business Development - Senior Business Development Specialist - VP, Portfolio & Member of the Board